Brown fat is specialized for energy expenditure, a process that is principally controlled by the transcriptional coactivator PGC-1a. Here, we describe a molecular network important for PGC-1a function and brown fat metabolism. We find that twist-1 is selectively expressed in adipose tissue, interacts with PGC-1a, and is recruited to the promoters of PGC-1a's target genes to suppress mitochondrial metabolism and uncoupling. In vivo, transgenic mice expressing twist-1 in the adipose tissue are prone to high-fat-diet-induced obesity, whereas twist-1 heterozygous knockout mice are obesity resistant. These phenotypes are attributed to their altered mitochondrial metabolism in the brown fat. Interestingly, the nuclear receptor PPARd not only mediates the actions of PGC-1a but also regulates twist-1 expression, suggesting a negative-feedback regulatory mechanism. These findings reveal an unexpected physiological role for twist-1 in the maintenance of energy homeostasis and have important implications for understanding metabolic control and metabolic diseases.
INTRODUCTION
Obesity and its associated metabolic diseases are caused by a long-term imbalance between energy intake and energy expenditure. Adipose tissues serve as major sites for the control of energy balance. They are present in two functionally distinct types: white fat and brown fat. White fat stores excess energy in the form of triglycerides and releases them in times of energy need. By contrast, brown fat is specialized for energy expenditure by dissipating energy as heat, a process termed as adaptive thermogenesis (Cannon and Nedergaard, 2004; Lowell and Spiegelman, 2000) . The unique metabolic property of brown fat is due to its high mitochondrial density and fuel oxidation capacity, and to its exclusive expression of uncoupling protein-1 (UCP1) in the inner mitochondrial membrane, which uncouples the mitochondrial proton gradient from ATP production. Given the fundamental importance of adipose tissues in the maintenance of systematic energy homeostasis, their functions must be tightly regulated.
As a heat-generating organ, brown fat plays a key part in the regulation of energy balance and obesity, as evidenced in rodent studies. For instance, either ablation of brown fat through expression of a toxic transgene or knockout of UCP1 leads to high susceptibility to diet-induced obesity (Kontani et al., 2005; Lowell et al., 1993) , whereas increase of UCP1 expression protects animals against diet-induced obesity (Kopecky et al., 1995) . However, human adults, unlike rodents and human neonates, do not possess discrete brown fat depots, and brown fat cells are dispersed within white fat, casting doubt on whether human brown fat cells are of physiological and/or pharmacological significance. On the other hand, it has long been observed that brown fat cells in humans have a remarkable capacity for recruitment and expansion in the presence of high sympathetic input or prolonged cold exposure (Garruti and Ricquier, 1992; Huttunen et al., 1981; Lean et al., 1986) . Moreover, recent tracer studies coupled with imaging technology demonstrated a much wider anatomic distribution of brown fat than was previously thought in several regions of the human body in normal individuals (reviewed in Nedergaard et al., 2007) . Both cell culture and animal model studies also suggest that white fat cells show plasticity and can be induced to acquire brown fat features (Seale et al., 2007; Tiraby and Langin, 2003) . Finally, only a small increase of brown fat activity appears to be sufficient to counteract obesity, as has been seen in mice that contain ectopic deposition of brown adipocytes in the skeletal muscle (Almind et al., 2007) or in mice that express UCP1 in the white fat at a very low level (Kopecky et al., 1995) . These observations revive the idea that brown fat remains an attractive therapeutic target tissue for obesity and associated diseases. Clearly, there is a strong need to understand the molecular basis underlying brown fat metabolism.
A central regulator in brown fat thermogenesis is the transcriptional coactivator PGC-1a (reviewed in Lin et al., 2005) . PGC-1a is predominantly expressed in the brown fat, and its expression is highly influenced by nutritional and environmental cues. Both overexpression and loss-of-function studies demonstrate that PGC-1a regulates the entire program of thermogenesis (Lin et al., 2005; Uldry et al., 2006) . As might be expected, regulatory mechanisms must be in place to fine-tune PGC-1a function. Studies have suggested that PGC-1a activity is positively regulated by several transcriptional regulators; these include Src-1, Sirt1, LRP130, and PRDM16 (Cooper et al., 2006; Lagouge et al., 2006; Picard et al., 2002; Puigserver et al., 1999; Rodgers et al., 2005; Seale et al., 2007) . Conversely, PGC-1a mRNA expression in the brown fat is inhibited by Rb protein and the orphan nuclear receptor SHP (Scime et al., 2005; Wang et al., 2005) . Two factors, GCN5 and p160 MBP , have been shown to suppress PGC-1a activity (Fan et al., 2004; Lerin et al., 2006) ; however, their functional relevance in brown fat metabolism is unknown. Interestingly, among all of the PGC-1a regulators identified so far, only PRDM16 displays a brown fat-selective expression pattern, with others being ubiquitously expressed in many tissues. Furthermore, the in vivo requirements for most of these factors in brown fat metabolism have not been addressed. Hence, despite these progresses, physiological regulators for PGC-1a in the brown fat largely remain to be identified. In particular, it is completely unclear how PGC-1a function is negatively modulated posttranscriptionally in the brown fat.
As a transcriptional coactivator, PGC-1a must dock to transcriptional factors to exert its biological function. In vitro, PGC-1a is found to interact with many transcriptional factors (Lin et al., 2005) . Among them are nuclear receptor peroxisome proliferator-activated receptors (PPARs) and estrogen-related receptors (ERRs), which themselves have been implicated in oxidative metabolism. However, the relative importance of these factors in brown fat metabolism is elusive. In the absence of PPARg or ERRa, UCP1 can still be induced (Seale et al., 2007 ; Villena et al., 2007) , indicating that neither PPARg nor ERRa is essential for UCP1 expression. Thus, the identity of the downstream major transcriptional factors that mediate PGC-1a function in the brown fat remains to be determined. In this manuscript, we identified a transcriptional network present in the brown fat that regulates and coordinates with PGC-1a. Twist-1, a helix-loop-helixcontaining transcriptional regulator, is expressed in embryonic stages and is important for early development (Chen and Behringer, 1995) , antiapoptosis (Sosic et al., 2003) , and osteoblast differentiation (Bialek et al., 2004) . Recent work also shows that twist-1 is overexpressed in many human cancers and cancer cell lines, thereby driving tumor invasion and metastasis (Ansieau et al., 2008; Ma et al., 2007; Yang et al., 2004) . Surprisingly, we find that twist-1 is mainly present in the adipose tissue and acts as a negative-feedback regulator of PGC-1a/PPARd-mediated brown fat metabolism. Our studies provide molecular insights into brown fat metabolism and have important implications in obesity and its associated metabolic diseases.
RESULTS

Twist-1 Is Selectively Expressed in the Adipose Tissue but Does Not Regulate Adipogenesis
To understand tissue-specific molecular components and pathways that control energy metabolism, we queried the human and mouse gene expression databases (Su et al., 2002) to search for transcriptional regulators that are preferentially expressed in the adipose tissue. One factor identified from these databases is twist-1. As shown in Figure 1A , quantitative PCR analyses confirmed that twist-1 was most abundantly expressed in the brown fat and white fat of adult mice, typically at a level more than10-fold higher than in other tissues. A similar expression profile was obtained with northern blot analyses (data not shown). Moreover, the twist-1 level was increased in mature adipocytes compared to preadipocytes in culture ( Figure 1B ). These data together led us to test whether twist-1 is involved in the adipogenesis of brown fat or white fat. To this end, we infected a brown fat preadipocyte cell line we generated (see below) with twist-1 expression retrovirus. Cells with stable viral integration were pooled and then induced to adipogenic differentiation. Retroviral twist-1 expressed at a level of 5-fold relative to its endogenous level in mature adipocytes, which corresponded to a 10-fold difference in preadipocytes ( Figure 1C ). Oil-red O staining revealed no obvious difference in lipid accumulation between cells overexpressing twist-1 and cells with vector alone (Figure 1C) . Similarly, retroviral overexpression of twist-1 in the white fat preadipocyte 3T3-L1 cells had no significant effect on adipogenic differentiation ( Figure S1 available online). Taken together, we found that the transcriptional regulator twist-1 is selectively expressed in the adipose tissue and, interestingly, that it does not participate in adipogenesis.
Twist-1 Inhibits the Transcriptional Activity of PGC-1a through Their Direct Interaction Given the lack of effect of twist-1 on adipogenesis, we considered whether twist-1 regulates energy dissipation, a predominant metabolic pathway in the brown fat controlled by PGC-1a. To begin testing this hypothesis, we examined whether twist-1 modulates the transcriptional activity of PGC-1a in cos-7 cells. Full-length PGC-1a fused with the DNA-binding domain (DBD) of yeast Gal4 had a robust transcription activity when assayed in a luciferase reporter driven by the Gal-UAS sequence (Puigserver et al., 1999) . In the presence of twist-1, the activity of Gal4-PGC-1a was strongly inhibited (Figure 2A ), whereas the activity of Gal4 DBD alone was unaffected. Twist-1 also inhibited PGC-1a-mediated activation of peroxisome proliferator-activated receptors (PPARs) ( Figure 2B and data not shown). On the other hand, twist-1 had no effect on the basal or agoniststimulated activity of PPARs ( Figure 2C ); this was due to the fact that, in cos-7 cells, there is little endogenous PGC-1a and the agonists-mediated activation of PPARs occurs presumably through recruitment of a different set of coactivators rather than PGC-1a. Thus, twist-1 is a specific inhibitor of PGC-1a.
We examined the possibility that coexpression of twist-1 may cause a decrease in the PGC-1a protein level and/or perturbation of its nuclear localization. Flag-tagged twist-1 and HAtagged PGC-1a were coexpressed in HEK 293 cells. Contrary to what is expected, PGC-1a protein was surprisingly stabilized in the presence of twist-1 ( Figure S2A ). Consistent with this observation, twist-1 blocked the ubiquitination of PGC-1a (data not shown). Immunofluorescence staining further demonstrates that expression of twist-1 stabilized PGC-1a and did not perturb its cellular localization pattern ( Figure S2B ).
We next determined whether twist-1 and PGC-1a physically associate. An interaction between these two proteins was readily detected ( Figures 2D and 2E ). There was also a weak association between twist-1 and PGC-1b ( Figure 2E ). However, interactions between twist-1 and other coactivators, such as p300 or src members, were almost undetectable ( Figure 2D ). We found that the first N-terminal 30 amino acids of twist-1, a small region that is conserved in the closely related member twist-2, was required for its interaction with PGC-1a, whereas the conserved C terminus was dispensable ( Figure 2F ). Not surprisingly, twist-2 also interacted with PGC-1a and suppressed its transcriptional activity ( Figure S3 ), but twist-2 expression in the brown fat and white fat is extremely low. The C-terminal half (aa 350 through the end) of PGC-1a mediated its interaction with twist-1 ( Figure 2G ). Importantly, deletion of this C-terminal half substantially increased its transcriptional activity compared to the fulllength form ( Figure 2H , left panel) and abolished twist-1's inhibitory effects ( Figure 2H, right panel) . These data demonstrate that inhibition of PGC-1a activity by twist-1 depends on the interaction between PGC-1a and twist-1, despite the fact that this interaction renders PGC-1a protein more stable.
Twist-1 Specifically Suppresses PGC-1a-Mediated Mitochondrial Oxidative Metabolism and Uncoupling
We asked whether the inhibition of PGC-1a transcriptional activity by twist-1 is of functional significance. We first addressed this question in differentiated C2C12 myotubules; these cells express little endogenous levels of PGC-1a and twist-1, therefore providing us a system by which to directly and unambiguously assess their functional interaction by ectopic expression. As shown by others and in Figure 3A , adenovirus expression of PGC-1a in the myotubules induced the expression of an array of genes involved in mitochondrial oxidative metabolism. Coexpression of twist-1 strongly negated the induction of these PGC-1a target genes ( Figure 3A ). Yet, twist-1 had little effect on the basal levels of these genes when PGC-1a was not present, nor did it have any effects on non-PGC-1a target genes, such as those involved in fatty acid synthesis. Moreover, the PGC-1a-stimulated oxygen consumption and fatty acid oxidation was reduced by coexpression of twist-1, whereas basal oxygen consumption and fatty acid oxidation was unaffected ( Figure S4 ). Twist-1 also inhibited PGC-1b-induced gene expression ( Figure S5 ) but was less robust, consistent with the weak physical association between twist-1 and PGC-1b. Taken together, these results indicate that twist-1 specifically targets PGC-1 to modulate oxidative metabolism.
Twist-1 belongs to a class of transcriptional regulators that contain a basic helix-loop-helix domain. The basic region recognizes a consensus DNA element called E-box. To rule out the possibility that the inhibitory effects of twist-1 require its binding to potential E-boxes on the promoters of PGC-1a target genes, we generated a twist-1 point mutation in residue E121, a conserved residue located in the basic region important for DNA binding (Atchley and Fitch, 1997) . Twist-1 binds to the E-box of the promoter of the GLI-Krupped family member GLI1 and activates its expression (Villavicencio et al., 2002) . The E121K mutant lost its ability to induce GLI1 expression ( Figure S6A ). However, this mutant was still capable of suppressing both the activity of PGC-1a in reporter assays and the expression of PGC-1a target genes ( Figures S6B and S6C ). These results demonstrate that suppression of PGC-1a target gene expression by twist-1 does not rely on its DNA-binding activity. This is consistent with the data showing that twist-1 has a widespread inhibitory effect on every PGC-1a target gene we examined ( Figure 3A and data not shown).
Both twist-1 and PGC-1a are mainly expressed in brown fat. To investigate the functional role of twist-1 in a more physiological setting, we generated an immortalized preadipocyte brown fat cell line (df/f) from newborn mice in which the PPARd alleles are floxed by the loxp sites. After differentiation, the df/f cells exhibited the characteristics of brown fat, including robust (H) Suppression of PGC-1a activity by twist-1 requires their interaction. Left panel, the transcriptional activity of Gal4-PGC-1a fusion constructs was measured in the absence of twist-1. Right panel, the fold of transcriptional activity in the presence of twist-1 relative to the activity in the absence of twist-1 for Gal4-PGC-1a fusion constructs was measured. Error bars represent standard error of the mean.
induction of PGC-1a and UCP1 gene expression (Figures S7A and S7B) . We tested whether twist-1 and PGC-1a associate at endogenous levels in brown fat cells. Because of the poor quality of the commercially available twist-1 antibody, we stably expressed HA-tagged twist-1 in df/f cells at a level that was 1.5-fold of its endogenous level. As shown in Figure 3B , 
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Oxidative metabolism Fatty acid synthesis PGC-1a antibody, but not control IgG, coimmunoprecipitated HA-twist-1 from nuclear extracts of differentiated brown fat cells, suggesting that an interaction between twist-1 and PGC-1a occurs at physiological levels in vivo.
To test the functional requirement of endogenous twist-1 in the brown fat cells, we used lentivirus to stably express shRNA against twist-1 in brown fat preadipocytes. After differentiation into mature adipocytes, we analyzed the expression of PGC-1a target genes. Stable knockdown of twist-1 led to a systematic increased expression of PGC-1a target genes, including UCP1 ( Figures 3C and S8) , whereas simultaneous knockdown of PGC-1a by RNAi adenovirus largely eliminated these effects ( Figure 3C ). Similar results were obtained when twist-1 was acutely knocked down with RNAi adenovirus in differentiated brown fat cells ( Figure 3D ), further suggesting that the observed effects of twist-1 are unrelated to adipogenesis. Moreover, depletion of twist-1 increased mitochondrial biogenesis, as judged by mitochondrial DNA content and electron microscopy ( Figures 3E and 3F) . Conversely, overexpression of twist-1 suppressed the expression of PGC-1a target genes ( Figure 3G ) and mitochondrial biogenesis ( Figure S9 ). These results demonstrate an important role of endogenous twist-1 in the regulation of mitochondrial oxidative metabolism in brown fat cells, most likely through negative modulation of endogenous PGC-1a function.
Transgenic Expression of Twist-1 in the Adipose Tissue Suppresses Brown Fat Metabolism To investigate whether the in vitro-identified regulatory role of twist-1 is relevant to in vivo fat metabolism, we generated twist-1 transgenic mice, driven by the aP2 promoter. The transgene was expressed at $2.5-fold its endogenous level ( Figure 4A ). Under normal chow diet, there was no difference in body weight between the transgenic mice and control littermates. However, when placed on a high-fat diet, the transgenic mice gained more body weight ( Figure 4B ) and accumulated substantially more lipids in the brown fat ( Figure 4C ), although they consumed a similar amount of food as controls ( Figure 4D ). Thus, a modest overexpression of twist-1 in the adipose tissue is sufficient to render the animals susceptible to high-fat-dietinduced obesity. Indeed, the transgene decreased the expression of UCP1 and fatty acid oxidation genes in the brown fat ( Figure 4E ). No gene expression difference was observed in the white fat ( Figure 4E) , consistent with the fact that there is little PGC-1a in this tissue. Next, we isolated brown fat tissue and measured oxygen consumption ex vivo. The rate of oxygen consumption was significantly lower in transgenic mice than in the control littermates ( Figure 4F ). Electron microscopy also revealed a clear reduction of mitochondria density in the brown fat of transgenic mice ( Figure 4G ). Finally, we monitored their body temperature when the mice were fed a high-fat diet. Whereas no differences were observed during the day time, the body temperature of the transgenic mice appeared to be lower at night compared to their control littermates ( Figure 4H ), probably reflecting an insufficiency of fat burning and heat production in the brown fat. These results together pinpoint a compromised brown fat function in the twist-1 transgenic mice.
Heterozygous Twist-1 Knockout Mice Have Increased Brown Fat Metabolism and Are Obesity Resistant
We asked whether twist-1 is indispensable for the regulation of energy homeostasis in vivo. Twist-1 homozygous knockout is embryonically lethal. We thus compared the metabolic phenotype of twist-1 heterozygous mice and their body weightmatched control littermates. When placed on a high-fat diet, the knockout animals showed a remarkable obesity-resistant phenotype ( Figure 5A ), accompanied by substantially less lipid accumulation in the brown fat ( Figure 5B ) and yet similar food consumption ( Figure 5C) . At the molecular level, expression of UCP1 and oxidation genes in the brown fat, but not in the white fat, was elevated ( Figure 5D ). As in the transgenic mice, the level of PGC-1a in the brown fat of the knockout mice was not significantly changed, consistent with the idea that the effects of twist-1 are due to its direct modulation of PGC-1a activity, not PGC-1a expression. Expression of liver genes important for fatty acid oxidation or fatty acid and triglyceride synthesis was also not affected ( Figure 5E ). Moreover, opposite to what was observed in the transgenic mice, the brown fat of heterozygous knockout mice displayed elevated oxygen consumption ( Figure 5F ) and mitochondrial biogenesis ( Figure 5G ), and their body temperature tended to be higher at night ( Figure 5H ). These results suggest that the level of twist-1 in vivo is quantitatively important for the control of energy homeostasis, providing compelling in vivo evidence supporting our model that twist-1 is a critical negative regulator of PGC-1a-mediated mitochondrial metabolism and uncoupling in the brown fat.
Twist-1 Inhibits Histone H3 Acetylation on the Promoters of PGC-1a Target Genes
We performed chromatin immunoprecipitation assays in brown fat cells to determine the molecular basis by which twist-1 suppresses PGC-1a function. We focused on the UCP1 promoter, as this promoter contains a well-defined PPAR-binding site that may underlie the induction of UCP1 by PGC-1a (Collins et al., 2004) . Both PGC-1a and twist-1 at their endogenous levels associated with the PPAR-binding site of the UCP1 promoter ( Figure 6A , and middle panel of Figure 6I ). Importantly, twist-1's association was markedly decreased when PGC-1a was knocked down by 40% (Figure 6B ), supporting the notion that twist-1 is recruited to the promoter by its interaction with PGC-1a. Consistent with the PGC-1a target gene expression data, expression of twist-1 suppressed PGC-1a-elicited Histone H3 acetylation ( Figure 6C ). Similar results were obtained with the carnitine palmitoyltransferase 1 (mCPT1) gene promoter ( Figures  6D and S10) . We found that twist-1 associated with the class II Histone deacetylase HDAC5 ( Figure 6E ) and recruited HDAC5 to the promoters of UCP1 and mCPT1 ( Figure 6F ), which could at least in part explain the loss of Histone H3 acetylation caused by twist-1.
PPARd Mediates the Actions of PGC-1a and Twist-1 in Brown Fat Cells
To further understand the molecular framework of this PGC-1a-twist-1 pathway, we sought to determine which transcription factor mediates the effects of PGC-1a in the brown fat and therefore could be linked to twist-1's suppressive function. As activation of PPARd promotes mitochondrial metabolism and uncoupling (Wang et al., 2003) , we considered PPARd as a candidate. To genetically test this possibility, we first examined whether there is a phenotypic overlap among loss of PPARd, PGC-1a acute knockdown, and twist-1 overexpression. We knocked out the PPARd gene (floxed alleles) in brown fat cells by cre recombinase adenovirus-mediated excision. Compared to the cells that were infected by GFP control virus, the PPARd-deficient cells (dÀ/À) displayed decreased expression of mitochondrial metabolic genes ( Figure 6G ) but normal adipogenesis ( Figure S11 ), a phenotype remarkably similar to those of PGC-1a acute knockdown ( Figures 3C and S12 ) and twist-1 overexpression ( Figure 3G ). In particular, loss of PPARd caused a dramatic reduction of UCP1 gene expression by more than 10-fold. The levels of PGC-1a, along with those of PPARg, PPARa, and ERRa, which are also involved in mitochondrial metabolism, remained unchanged ( Figure 6G ). This indicates an essential, cell-autonomous requirement for PPARd in the expression of some, but not all, of the PGC-1a target genes. To further test whether PPARd acts downstream of PGC-1a, we measured UCP1 induction by the b3-adrenergic receptor agonist in PPARd-deficient brown fat cells. The b3-adrenergic receptor agonist stimulates UCP1 expression through increasing both the activity and expression level of PGC-1a (Collins et al., 2004) . Although the PPARd-deficient cells had similar levels of PGC-1a as the wild-type cells, they were almost completely unresponsive to the agonist in the induction of UCP1 ( Figure 6H ). Indeed, in the absence of PPARd, PGC-1a was no longer able to associate with the UCP1 promoter, which consequently resulted in the loss of association of twist-1 with the promoter ( Figure 6I ). Finally, we placed floxed PPARd mice carrying the aP2-cre transgene at 4 C for 6 hr. These animals' ability to maintain their body temperature during the last hour of the cold exposure was compromised compared to their control littermates without aP2-cre ( Figure 6J ), further indicating a functional convergence of PPARd and PGC-1a. There was $30% of PPARd expression remaining in the brown fat of the knockout mice ( Figure 6J ) (Barak et al., 2002) ; this might account for the normal cold response during early time points. Together, these lines of genetic and biochemical evidence suggest that PPARd functions as a key mediator downstream of PGC-1a and twist-1.
Twist-1 Is Induced by PPARd Activation in Brown Fat
We explored how twist-1 expression might be regulated. Treatment of differentiated brown fat cells with the PPARd agonist, but not the agonist for PPARg or PPARa, induced twist-1 expression ( Figure 7A ). This induction was PPARd dependent, as the agonist had no effect when the PPARd gene was deleted. Interestingly, similar levels of twist-1 were observed in PPARd-deficient cells relative to wild-type cells ( Figure 7A) ; this pattern differs from the target genes involved in metabolism described in Figure 6G , indicating that PPARd is not required for the maintenance of basal twist-1 expression. There are two probable PPAR-binding sites in the twist-1 promoter, located in the À3.43 and À1.88 kb regions, respectively. In the basal conditions, neither PPARd nor PPARg was associated with them. Upon addition of their respective agonists, PPARd, but not PPARg, was recruited to the distal site ( Figure 7B ), although PPARg evidently associated with the PPAR-binding site in its target gene aP2 promoter in the same experiments; these data are consistent with the agonist-dependent regulation of twist-1 by PPARd. To determine whether activation of PPARd induces twist-1 expression in animals, we analyzed tissue RNA samples from wild-type C57BL6 mice treated with vehicle or the PPARd agonist. The level of twist-1 in brown fat tissue was induced 2.8-fold by the agonist ( Figure 7C ). However, no significant changes were observed in animals treated with agonists for PPARg or PPARa ( Figure 7C ). Our data suggest that twist-1 serves as a negative-feedback regulatory loop to tightly modulate the PGC-1a/PPARd-controlled brown fat metabolism ( Figure 7E ). Intriguingly, the twist-1 level was elevated in the brown fat of obese mice ( Figure 7D ). This, coupled with decreases of PGC-1a (Kakuma et al., 2000) and PPARd ( Figure S13 ) in these animals, may further aggravate the state of obesity.
DISCUSSION
It has now become increasingly appreciated that brown fat cells may play an important part in human energy homeostasis. A better understanding of the molecular basis underlying its unique metabolic property is obviously the first step in taking full advantage of this cell type as a target for obesity and associated diseases. Whereas previous work has demonstrated a central role for PGC-1a in governing brown fat metabolism, the other factors involved and, in particular, how these potential factors functionally and mechanistically interact and coordinate with PGC-1a are poorly understood. Our results presented here reveal a transcriptional network that provides insights into this question. We demonstrate that twist-1 is physiologically critical in brown fat metabolism by directly antagonizing PGC-1a. Moreover, twist-1 constitutes part of a feedback regulatory loop in which the nuclear receptor PPARd not only acts downstream to mediate, at least in part, the function of PGC-1a, but also controls twist-1 expression. Interestingly, this brown fatspecific regulatory network appears to be exclusively involved in energy dissipation, but not in fat cell formation.
Twist-1 is highly expressed at the embryonic stage and is induced in cancer cells, consistent with its roles in early development and tumor metastasis, respectively. Unexpectedly, at the postnatal stage, twist-1 is mainly expressed in the adipose tissue. Our studies performed both in vitro and in vivo elucidate that twist-1 specifically regulates PGC-1a-controlled oxidative metabolism and uncoupling in the brown fat. In particular, adipose twist-1 transgenic mice and the heterozygous knockout display completely opposite body weight gain and body temperature profiles. These phenotypes can be largely explained by their altered PGC-1a target gene expression profiles, oxygen consumption, and mitochondrial biogenesis in the brown fat.
Our results clearly establish twist-1 as a metabolic brake for energy expenditure in the brown fat, and that its expression level is critically important for the maintenance of whole-body energy homeostasis. At present, the function of twist-1 in the white fat is unclear. It is possible that twist-1 may regulate additional pathways related to adipocyte biology.
One question is how the interaction of twist-1 and PGC-1a leads to suppression of PGC-1a function. Twist-1 neither destabilizes PGC-1a nor perturbs its nuclear localization. We also found no evidence that the interaction displaces PGC-1a from its target gene promoters. Instead, twist-1 is recruited by PGC1a to the PGC-1a target gene promoters and thus exerts its inhibitory function locally. This mode of action is clearly different from the one employed in the suppression of Runx2 during bone development; there, twist-1 blocks Runx2 association with the target gene promoter through its interaction with the DNAbinding domain of Runx2 (Bialek et al., 2004) . Interestingly, the regions of twist-1 that interact with PGC-1a and Runx2 appear to be different, located in the N terminus and C terminus, respectively; this further indicates a versatile nature of twist-1 in gene regulation. The recruitment of twist-1 to PGC-1a target gene promoters causes a dramatic decrease of Histone H3 acetylation, likely due to a subsequent recruitment of Histone deacetylase HDAC5. These results together outline a plausible underlying mechanism by which twist-1 modulates brown fat metabolism. Other potential mechanisms are also possible. For example, twist-1 was shown to inhibit p300 acetyltransferase activity in vitro (Hamamori et al., 1999) . However, we were unable to detect any association of p300 with the UCP1 promoter. Another acetyltransferase, SRC-1, has been shown to regulate UCP1 expression (Picard et al., 2002) . Indeed, we find that SRC-1 is present on the UCP1 promoter, but this association is not affected by twist-1 (unpublished data), consistent with the data showing that these two proteins do not interact.
Our studies further uncovered PPARd as an integral component in coordinating the actions of PGC-1a and twist-1 in brown fat metabolism. The requirement for PPARd on expression of PGC-1a target genes occurs in the context of normal expression of PPARg, PPARa, and ERRa. Previous work in other cell systems suggests that the transcription factor YY1 and ERRa act downstream of PGC-1a in mitochondrial oxidative metabolism (Cunningham et al., 2007; Mootha et al., 2004; Schreiber et al., 2004) . Those studies and ours presented here indicate that how PGC-1a is mediated downstream is more complex, and is likely to be cellular context dependent and/or promoter dependent. Although by no means excluding the involvement of other transcription factors, our genetic analyses suggest that in brown fat cells PPARd is an important mediator, in particular for UCP1 expression. This idea is strengthened by our observation that fat-specific PPARd knockout mice are compromised in maintaining body temperature during cold exposure. Furthermore, we find that PPARd, but not PPARa or PPARg, binds to the twist-1 promoter and directs twist-1 expression both in brown fat cell culture and in whole animals, suggesting a feedback regulatory mechanism. As PPARd is a lipid sensor that is activated by fatty acids (Chawla et al., 2003) , the transcriptional network described here would presumably allow brown fat to respond to the body's nutrient status to ensure energy homeostasis.
In summary, our results provide important molecular insights into how the PGC-1a-controlled energy expenditure pathway is modulated and coordinated in the brown fat. Pharmacologically increasing PGC-1a activity and/or expression is considered a therapeutic strategy for metabolic diseases (Baur et al., 2006; Feige et al., 2008; Lagouge et al., 2006) . Our data indicate that a decreasing twist-1 level or disrupting its interaction with PGC-1a may offer an alternative strategy.
EXPERIMENTAL PROCEDURES Viruses
Adenoviruses for overexpression and knockdown were generated by using the AdEasy-1 system (He et al., 1998) . The PGC-1a RNAi adenovirus construct was kindly provided by Dr. Marc Montminy (Koo et al., 2004) . All adenoviruses were purified with cesium chloride ultracentrifugation, and virus titers were determined in HEK 293 cells by scoring GFP-positive cells. Twist-1 RNAi lentivirus constructs were obtained from Addgene.
Adenovirus infection was performed in differentiated cells unless otherwise indicated. GFP control adenovirus was added, if needed, to ensure a similar degree of infection in different samples. Assays were performed 2 days after infection.
Generation and Differentiation of Brown Fat Cells
Immortalized brown fat preadipocytes (df/f) were generated as described (Tseng et al., 2004) . We used mice containing floxed PPARd alleles (Barak et al., 2002) that had been backcrossed with C57BL6 for nine generations. Details are available in Supplemental Experimental Procedures.
Luciferase Reporter Assays, Coimmunoprecipitation, and Chromatin Immunoprecipitation Luciferase reporter assays, coimmunoprecipitation, and chromatin immunoprecipitation are described in Supplemental Experimental Procedures.
Animals
The aP2 promoter-directed twist-1 transgenic mouse line was generated in a SV129/C57BL6 mixed background and was backcrossed with C57BL6 for four generations. Heterozygous twist-1 knockout mice in a C57BL6 background were purchased from Jackson Laboratory, and cohorts were generated by crossing with wild-type C57BL6. Conditional PPARd floxed mice (Barak et al., 2002) and aP2-Cre transgenic mice were described. Littermate controls were used in all of the experiments. A normal diet containing 4% (w/w) fat was obtained from Harlan Teklad. A high-fat diet containing 35% (w/w) fat content was obtained from Bioserv (Product #F3282). Food consumption was measured daily for individually caged mice for 2 weeks. The University of Massachusetts Medical School's Institutional Animal Care and Use Committee approved all of the animal studies.
Body Temperature
Mice were implanted with paraffin-coated iButtons (DS1922T-F5, Embedded data systems) into their peritoneal cavities as described (Davidson et al., 2003) . Mice were allowed to recover for 2 weeks. Body temperature was then recorded at a 10 min sampling interval. The data were retrieved with a data reader.
Oxygen Consumption Assays
Brown fat was isolated and chopped into small pieces. Equal amounts (30 mg) were used in 5 ml DPBS supplemented with 25 mM glucose, 1 mM pyruvate, and 2% BSA. Respiration was measured with a Clark-type electrode (YSI model 5300).
Experiments with PPAR Agonists
In brown fat adipocyte culture, differentiated cells were treated with vehicle, PPARd agonist GW501516 (0.1 mM), or PPARg agonist rosiglitazone (1 mM) for 24 hr. For in vivo experiments, total RNA samples from wild-type C57BL6 mice treated with GW501516 were generated previously (Wang et al., 2004) . Wild-type C57BL6 mice were gavaged daily with rosiglitazone (30 mg/kg per day), PPARa agonist GW7647 (3 mg/kg per day), or vehicle for 1 week.
Electron Microscopy
Details on electron microscopy are available in Supplemental Experimental Procedures. We used ImageJ software to calculate mitochondrial area and cellular area in individual micrographs, and mitochondrial density was expressed as a percentage of cellular area. In data presented in Figures 4G  and 5G , showing results of animal experiments, the area of the lipid droplet was not included in the cellular area to avoid exaggerating the difference of mitochondrial density.
Statistical Analysis
The Student's t test (two-tailed) was used for statistical analysis. p < 0.05 was considered significant. Data are presented as mean ± standard error of the mean.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, 13 figures, and 1 table and are available with this article online at http://www.cell.com/ supplemental/S0092-8674(09)00136-6.
